Current Edition

ABBVIE

AbbVie keeps up dealmaking pace in neuroscience

Dive Brief: AbbVie announced Friday a new agreement with its longtime partner Gedeon Richter to research and develop dopamine-regulating treatments for neuropsychiatric diseases.   According …

Continue Reading →
diseases

Star Therapeutics emerges with plans to treat rare diseases through a solar system of drug companies

Few things are as human as gazing into the night sky. And yet, after thousands of years, we know only a little about what we’re …

Continue Reading →
antibiotics

The pipeline of new antibiotics is drying up. A bill in Congress aims to change that

Bacteria that can defeat current antibiotic drugs are sometimes called “the next pandemic.” Already, infections from them are believed to cause or contribute to more …

Continue Reading →
diseases

Gene Therapies That Could Transform Diseases Get Easier FDA Path

New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by …

Continue Reading →